跳至主要内容
临床试验/NCT05080933
NCT05080933已完成不适用

Extracorporeal Membrane Oxygenation for COVID-19 and Influenza H1N1 Associated Acute Respiratory Distress Syndrome: a Multi-centre Retrospective Cohort Study

University of Turin, Italy1 个研究点 分布在 1 个国家目标入组 308 人开始时间: 2009年8月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
308
试验地点
1
主要终点
All cause mortality on day 60 after ECMO initiation

研究概览

简要总结

Objective: Veno-venous ECMO has been used as a rescue therapy for patients with severe ARDS associated to influenza A H1N1 and COVID19 viral pneumonia. Little is known about outcome of these patients who required extracorporeal support.

Research question: To compare outcome of patients who required VV ECMO for Covid19 and H1N1 associated ARDS

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COVID-19 or influenza A H1N1 (suspected or confirmed) diagnosis
  • Severe ARDS (according to Berlin Definition)
  • Invasive mechanical ventilation through endotracheal tube or tracheostomy

排除标准

  • Age<18 years

结局指标

主要结局

All cause mortality on day 60 after ECMO initiation

时间窗: 60 days

次要结局

  • Hospital mortality on day 90 after ECMO initiation(90 days)
  • ECMO duration(90 days)
  • ECMO associated hemorrhagic complications(60 days)
  • ECMO associated mechanical complications(60 days)
  • Invasive mechanical ventilation duration(90 days)
  • ECMO related haemorrhagic complications(90 days)
  • ECMO related mechanical complications(90 days)
  • ICU length of stay(90 days)
  • Hospital length of stay(90 days)

研究者

发起方
University of Turin, Italy
申办方类型
Other
责任方
Principal Investigator
主要研究者

Vito Fanelli MD, PhD

MD, PhD

University of Turin, Italy

研究点 (1)

Loading locations...

相似试验